Iron status biomarkers
Pro Research Analysisby 
Searched over 200M research papers
Overview of Iron Status Biomarkers
Iron status biomarkers are essential tools for diagnosing and managing iron deficiency, iron overload, and related disorders. The most commonly used biomarkers include serum ferritin, transferrin saturation, serum iron, total iron-binding capacity (TIBC), and soluble transferrin receptor (sTfR). Each biomarker provides unique information about iron metabolism and storage, but their interpretation can be influenced by factors such as inflammation, age, sex, and genetic background Semenova2024Lynch2018Pfeiffer2017.
Common Iron Status Biomarkers: Serum Ferritin, Transferrin Saturation, and sTfR
Serum ferritin is widely used to assess iron stores in the body. Low ferritin indicates iron deficiency, while high ferritin can suggest iron overload or inflammation. However, ferritin is an acute-phase reactant and can be elevated in the presence of infection or inflammation, complicating its interpretation Semenova2024Lynch2018Pfeiffer2017. Transferrin saturation, calculated from serum iron and TIBC, reflects the proportion of transferrin bound to iron and is useful for detecting both iron deficiency and overload Semenova2024Lynch2018. Soluble transferrin receptor (sTfR) is less affected by inflammation and provides information about functional iron deficiency, but its use is limited by a lack of assay standardization and universally accepted cutoffs Semenova2024Pfeiffer2017.
Emerging and Specialized Iron Biomarkers: Hepcidin and Reticulocyte Indices
Newer biomarkers such as hepcidin and reticulocyte indices are being explored for their potential to improve iron status assessment. Hepcidin is a key regulator of iron homeostasis and may help distinguish between iron deficiency and inflammation-related changes in iron metabolism. Reticulocyte hemoglobin content and related indices can provide early indications of iron-restricted erythropoiesis, especially in complex clinical settings like sepsis, where standard biomarkers may be unreliable Semenova2024Czempik2023Lynch2018.
Genetic and Population Differences in Iron Biomarkers
Genetic factors significantly influence iron status biomarkers. Large-scale studies have identified numerous genetic loci associated with variations in serum iron, ferritin, transferrin saturation, and TIBC. These genetic differences can affect iron metabolism and the risk of iron-related diseases . Population studies show that individuals of East Asian ancestry may have higher iron stores compared to those of Northern European ancestry, even in young, healthy adults, highlighting the importance of considering ancestry in iron status assessment .
Age, Sex, and Menopausal Status Effects on Iron Biomarkers
Iron biomarkers change with age, sex, and menopausal status. Men generally have higher iron status than women, but after menopause, women experience a marked increase in iron biomarkers such as ferritin, hepcidin, and transferrin saturation, sometimes surpassing levels seen in men. These changes may contribute to increased risk of chronic diseases in older adults, especially postmenopausal women Merlo2023Lynch2018.
Clinical and Public Health Implications
Iron status biomarkers are crucial for diagnosing iron deficiency anemia, monitoring iron therapy, and assessing the risk of iron overload. However, their interpretation must account for confounding factors like inflammation, infection, and life stage. In clinical practice, combining multiple biomarkers improves diagnostic accuracy. In research and public health, models that integrate sTfR and ferritin, such as the total body iron (TBI) model, provide a more comprehensive assessment of iron status Lynch2018Pfeiffer2017.
Iron Biomarkers and Disease Risk
Recent studies using Mendelian randomization have linked iron status biomarkers to the risk of various diseases. Higher iron biomarkers are associated with a lower risk of coronary artery disease but may increase the risk of type 2 diabetes. Iron status also appears to influence the risk of retinal degenerative diseases and anxiety disorders, with different biomarkers showing protective or adverse effects depending on the condition Moksnes2021Liu2024Qu2024+1 MORE.
Limitations and Future Directions
Standard iron biomarkers can be unreliable in certain clinical situations, such as sepsis or chronic inflammation, where new biomarkers or combined models may offer better diagnostic value Czempik2023Pfeiffer2017. Ongoing research aims to refine biomarker interpretation, improve assay standardization, and develop new indicators that can more accurately reflect iron status across diverse populations and clinical scenarios Lynch2018Pfeiffer2017.
Conclusion
Iron status biomarkers are indispensable for evaluating iron deficiency, overload, and related health risks. Their effective use requires understanding their strengths, limitations, and the influence of genetic, demographic, and clinical factors. Combining multiple biomarkers and considering emerging indicators can enhance the accuracy of iron status assessment and improve patient care and public health outcomes Semenova2024Lynch2018Pfeiffer2017.
Sources and full results
Most relevant research papers on this topic